BlackRock and Vanguard Increased Holdings in Five Drugmakers in Q3
Quarterly filings show BlackRock and Vanguard Capital Management increased holdings in Sellas Life Sciences, ImmunityBio, Iovance Biotherapeutics, Merck and Eli Lilly.
Quarterly filings show BlackRock and Vanguard Capital Management increased holdings in Sellas Life Sciences, ImmunityBio, Iovance Biotherapeutics, Merck and Eli Lilly.